Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.44 |
| ▸ | GABRD | O14764 | 2/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.44 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.44 |
| ▸ | GABRE | P78334 | 2/20 | 0.44 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.44 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.44 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.44 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL908287 | 0.82 | CES2 (0.46) | AKR1B1LMNAGAATSHRKDM4E | |
| SCHEMBL299357 | 0.80 | GAA (0.47) | AKR1B1LMNAGAATSHRKDM4E | |
| SCHEMBL25327233 | 0.78 | THRB (0.46) | AKR1B1LMNAGAATSHRKDM4E | |
| SCHEMBL26729959 | 0.78 | HDAC1 (0.44) | HDAC1HDAC6AKR1B1LMNAGAA | |
| SCHEMBL2728544 | 0.78 | GAA (0.50) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL30192663 | 0.78 | GAA (0.50) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1000775 | 0.77 | GABRP (0.47) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| Methane SCHEMBL28521569 | 0.76 | GAA (0.48) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL583915 | 0.75 | AKR1B1 (0.60) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29009790 | 0.75 | RXRA (0.50) | AKR1B1LMNAGAATSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9896417-B2 | Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof | MACROPHAGE PHARMA LIMITED (GB) | 2018-02-20 | — | — | US | disclosed |
| US-9896417-B2 | Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof | MACROPHAGE PHARMA LIMITED (GB) | 2018-02-20 | — | — | US | disclosed |
| US-20160297760-A1 | TERT-BUTYL N-[2-ETHYL]-L-ALANINATE OR A SALT,HYDRATE OR SOLVATE THEREOF | MACROPHAGE PHARMA LIMITED (GB) | 2016-10-13 | — | — | US | disclosed |
| US-20160297760-A1 | TERT-BUTYL N-[2-ETHYL]-L-ALANINATE OR A SALT,HYDRATE OR SOLVATE THEREOF | MACROPHAGE PHARMA LIMITED (GB) | 2016-10-13 | — | — | US | disclosed |
| US-8252833-B2 | Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists | GLAXO GROUP LIMITED (GB) | 2012-08-28 | — | — | US | disclosed |
| EP-2457897-A1 | BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS | Glaxo Group Limited (GB) | 2012-05-30 | — | — | EP | disclosed |
| EP-1979316-A1 | BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS | GLAXO GROUP LIMITED (GB) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007088190-A1 | BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS | GLAXO GROUP LIMITED (GB) | 2007-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297760-A1 | TERT-BUTYL N-[2-ETHYL]-L-ALANINATE OR A SALT,HYDRATE OR SOLVATE THEREOF | MAPK1, MAPK6, MAPK15 | GABRP 4679/4885GABRD 4688/4885GABRA1 4637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.